BMS to sell off Diabetes Unit?

Quote
If they are killing Diabetes R&D and articulating an Immuno/ Onco focus as well as indicating to the street they would sell their stake to AZ. What more do you need? Are you hitting the numbers this year? You need a plan!
 




Anonymous said:
Don`t be so naive. Everything you say is exactly what Nss said last year with abilify. Mgmt even said on stage at national meeting that sales growth was strong and no cuts would even be looked at for at least 18 months. 6 months later, 700 people and an entire profitable division were gone. Everything here at bms is fools gold and they will sell their souls for the right price.
Click to expand...

News flash dumb ass we didn't own ability! That's why you we're let go. Nothing more nothing less.
 




Anonymous said:
Okay dumb ass!!! Here you go-
Neuroscience Division - Abilify
Mead Johnson - 2009, women having babies everyday all day and providing nutritional supplements to their babies.
Zimmer - 2001, orthopaedics

Got it dumb ass!!!! Don't write unless you know what you're talking about.
Click to expand...

I don't write unless I know fuck face and here is my proof to make you look like the dumb ass you really are!
First: neuroscience we didn't own abilify dumb ass!! We didn't sell it off we gave it back. Do you feel stupid yet? Ok let me go on!
Second: we didn't sell off Mead Johnson you dumb fuck we spilt off. Their profit is still our profit. You feel like a dumb as yet?
The only thing you got was the Zimmer thing and honestly I don't what the fuck that is! Bottom you are a dumb fuck and deserved whatever happens to you!
That is all!!
 








Anonymous said:
I don't write unless I know fuck face and here is my proof to make you look like the dumb ass you really are!
First: neuroscience we didn't own abilify dumb ass!! We didn't sell it off we gave it back. Do you feel stupid yet? Ok let me go on!
Second: we didn't sell off Mead Johnson you dumb fuck we spilt off. Their profit is still our profit. You feel like a dumb as yet?
The only thing you got was the Zimmer thing and honestly I don't what the fuck that is! Bottom you are a dumb fuck and deserved whatever happens to you!
That is all!!
Click to expand...

Yikes!! You're writing reflects a lot of anger, hopefully you're able to communicate without having to use foul language . . . seems like the OP was making a point in that BMS has sold off divisions and a contract ended, so anything is possible in sales.

You might wanna check out the BMS website site and look at the pipeline. Not promising for diabetes. Get your resume ready cause the diabetes division won't be as hearty as it is today.
 




Anonymous said:
I don't write unless I know fuck face and here is my proof to make you look like the dumb ass you really are!
First: neuroscience we didn't own abilify dumb ass!! We didn't sell it off we gave it back. Do you feel stupid yet? Ok let me go on!
Second: we didn't sell off Mead Johnson you dumb fuck we spilt off. Their profit is still our profit. You feel like a dumb as yet?
The only thing you got was the Zimmer thing and honestly I don't what the fuck that is! Bottom you are a dumb fuck and deserved whatever happens to you!
That is all!!
Click to expand...

Keyboard tough guy! You must have been top of your class with your foul mouth and bad grammar. You feel like a dumb AS yet?
 












Company going to rebadge employees.

2.37 "Rebadged Employee” means an Eligible Employee whose employment with the Employer is terminated by the Employer in connection with the outsourcing of work by the
Employer in a transaction with a third‑party vendor where the Eligible Employee is offered a Negotiated Job Offer and:
(a) (i) accepts the Negotiated Job Offer; or (ii) declines the Negotiated Job Offer, provided the Negotiated Job Offer is not an Offer Outside Geographic Parameters; and
(b) remains employed with the Employer through the date established by the Employer as the employee's Separation Date unless the Employer expressly waives this provision.
Whether an Eligible Employee is a Rebadged Employee shall be determined by the Employer or Parent in its sole discretion. An Eligible Employee shall not be considered to be a Rebadged Employee if his or her employment with the Employer (i) does not end as set forth in this Section 2.32 (ii) ends due to the declination of a Negotiated Job Offer that is an Offer Outside Geographic Parameters, or (iii) ends as a result of any of the events described in Section 3.1(e).
For the avoidance of doubt, a Rebadged Employee shall not be considered to have experienced a Termination due to Workforce Restructuring for purposes of the Plan.
 




Anonymous said:
Company going to rebadge employees.

2.37 "Rebadged Employee” means an Eligible Employee whose employment with the Employer is terminated by the Employer in connection with the outsourcing of work by the
Employer in a transaction with a third‑party vendor where the Eligible Employee is offered a Negotiated Job Offer and:
(a) (i) accepts the Negotiated Job Offer; or (ii) declines the Negotiated Job Offer, provided the Negotiated Job Offer is not an Offer Outside Geographic Parameters; and
(b) remains employed with the Employer through the date established by the Employer as the employee's Separation Date unless the Employer expressly waives this provision.
Whether an Eligible Employee is a Rebadged Employee shall be determined by the Employer or Parent in its sole discretion. An Eligible Employee shall not be considered to be a Rebadged Employee if his or her employment with the Employer (i) does not end as set forth in this Section 2.32 (ii) ends due to the declination of a Negotiated Job Offer that is an Offer Outside Geographic Parameters, or (iii) ends as a result of any of the events described in Section 3.1(e).
For the avoidance of doubt, a Rebadged Employee shall not be considered to have experienced a Termination due to Workforce Restructuring for purposes of the Plan.
Click to expand...

You were up at midnight writing this! Damn chicken little relax. You must be an old NSS rep.
 




Anonymous said:
Company going to rebadge employees.

2.37 "Rebadged Employee” means an Eligible Employee whose employment with the Employer is terminated by the Employer in connection with the outsourcing of work by the
Employer in a transaction with a third‑party vendor where the Eligible Employee is offered a Negotiated Job Offer and:
(a) (i) accepts the Negotiated Job Offer; or (ii) declines the Negotiated Job Offer, provided the Negotiated Job Offer is not an Offer Outside Geographic Parameters; and
(b) remains employed with the Employer through the date established by the Employer as the employee's Separation Date unless the Employer expressly waives this provision.
Whether an Eligible Employee is a Rebadged Employee shall be determined by the Employer or Parent in its sole discretion. An Eligible Employee shall not be considered to be a Rebadged Employee if his or her employment with the Employer (i) does not end as set forth in this Section 2.32 (ii) ends due to the declination of a Negotiated Job Offer that is an Offer Outside Geographic Parameters, or (iii) ends as a result of any of the events described in Section 3.1(e).
For the avoidance of doubt, a Rebadged Employee shall not be considered to have experienced a Termination due to Workforce Restructuring for purposes of the Plan.
Click to expand...


Wow, never saw that before! Scary. Where did u find it? I wish some NSS would comment.
 




Anonymous said:
http://www.ft.com/cms/s/0/6704b8d8-4894-11e3-8237-00144feabdc0.html#axzz2k615g5TU

Talks about yesterday's announcement that they are dropping diabetes R&D, and the poor performance of Bydureon. Says AZ might be a logical buyer of the franchise.
Click to expand...

Look at BMS and AZ pipeline, neither have invested in diabetes research. We're promoting me too drugs and with the affordable care act's emphasis on generics, the only way pharma can be profitable is to have a unique drug. There doesn't need to be variety of like meds.
 








Anonymous said:
Company going to rebadge employees.

2.37 "Rebadged Employee” means an Eligible Employee whose employment with the Employer is terminated by the Employer in connection with the outsourcing of work by the
Employer in a transaction with a third‑party vendor where the Eligible Employee is offered a Negotiated Job Offer and:
(a) (i) accepts the Negotiated Job Offer; or (ii) declines the Negotiated Job Offer, provided the Negotiated Job Offer is not an Offer Outside Geographic Parameters; and
(b) remains employed with the Employer through the date established by the Employer as the employee's Separation Date unless the Employer expressly waives this provision.
Whether an Eligible Employee is a Rebadged Employee shall be determined by the Employer or Parent in its sole discretion. An Eligible Employee shall not be considered to be a Rebadged Employee if his or her employment with the Employer (i) does not end as set forth in this Section 2.32 (ii) ends due to the declination of a Negotiated Job Offer that is an Offer Outside Geographic Parameters, or (iii) ends as a result of any of the events described in Section 3.1(e).
For the avoidance of doubt, a Rebadged Employee shall not be considered to have experienced a Termination due to Workforce Restructuring for purposes of the Plan.
Click to expand...

Very common with contract reps.
 








I agree this might happen but you people keep comparing this to neuroscience and abilify! It's hands down without a doubt not the same. Do you not think BMS wouldn't have kept selling abilify if they could have? The 50/50 agreement was up that's all. Again this might happen and it won't until the decision on Dec 12 with the advisory board. Nothing will happen until dapa does or doesn't get approved or the FDA grants us the use of the pen.
 








Anonymous said:
I agree this might happen but you people keep comparing this to neuroscience and abilify! It's hands down without a doubt not the same. Do you not think BMS wouldn't have kept selling abilify if they could have? The 50/50 agreement was up that's all. Again this might happen and it won't until the decision on Dec 12 with the advisory board. Nothing will happen until dapa does or doesn't get approved or the FDA grants us the use of the pen.
Click to expand...

Money Talks: There are a lot of similarities to Abilify.The Abilify agreement had not expired and had two more years on it when Otsuka made an offer to buy marketing rights. BMS still receives a portion of Abilify sales they just no longer market it.

Companies do this when a sales force's products do not align with their long term goals. This is not to say that BMS is going to sell off diabetes. If they did it would negativly impact their stature in the Pharma world. Money Talks however and selling marketing rights would bring a huge influx of cash.
 




Anonymous said:
Money Talks: There are a lot of similarities to Abilify.The Abilify agreement had not expired and had two more years on it when Otsuka made an offer to buy marketing rights. BMS still receives a portion of Abilify sales they just no longer market it.

Companies do this when a sales force's products do not align with their long term goals. This is not to say that BMS is going to sell off diabetes. If they did it would negativly impact their stature in the Pharma world. Money Talks however and selling marketing rights would bring a huge influx of cash.
Click to expand...

well said amigo and with some actual knowledge behing the post. bms parted with abilify cuz the cold hard cash that otsuka was willing to pay them. not sure of az bank account but rest assured if they flash dinero that bms likes, diabetes will be spun off.
 








Top Bottom
Back
Quote